187 related articles for article (PubMed ID: 17218949)
1. Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag.
Sabbioni S; Callegari E; Spizzo R; Veronese A; Altavilla G; Corallini A; Negrini M
Cancer Gene Ther; 2007 Mar; 14(3):297-305. PubMed ID: 17218949
[TBL] [Abstract][Full Text] [Related]
2. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
[TBL] [Abstract][Full Text] [Related]
3. Host range analysis of simian virus 40, BK virus and chimaeric SV40/BKV: relative expression of large T-antigen and Vp1 in infected and transformed cells.
O'Neill FJ; Carney H; Hu Y
Dev Biol Stand; 1998; 94():191-205. PubMed ID: 9776240
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumorigenicity and anchorage-independent growth of BK virus-transformed mouse cells by human chromosome 11.
Negrini M; Castagnoli A; Pavan JV; Sabbioni S; Araujo D; Corallini A; Gualandi F; Rimessi P; Bonfatti A; Giunta C
Cancer Res; 1992 Mar; 52(5):1297-303. PubMed ID: 1310642
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
[TBL] [Abstract][Full Text] [Related]
8. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
9. Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1.
Corallini A; Possati L; Trabanelli C; Giraudo E; Rocchetti R; Talevi S; Caputo A; Bussolino F; Barbanti-Brodano G
Carcinogenesis; 2003 Sep; 24(9):1435-44. PubMed ID: 12844479
[TBL] [Abstract][Full Text] [Related]
10. Virus specific antigens in BK virus-transformed cells detected by cell-mediated immune reactions.
Karjalainen HE; Laaksonen AM; Mäntyjärvi RA
Med Biol; 1983 Feb; 61(1):73-8. PubMed ID: 6302408
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic transformation by BK virus and association with human tumors.
Tognon M; Corallini A; Martini F; Negrini M; Barbanti-Brodano G
Oncogene; 2003 Aug; 22(33):5192-200. PubMed ID: 12910256
[TBL] [Abstract][Full Text] [Related]
12. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
Gordon J; Del Valle L; Otte J; Khalili K
Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice.
Sonwane AA; Dahiya SS; Saini M; Chaturvedi VK; Singh RP; Gupta PK
Res Vet Sci; 2012 Aug; 93(1):498-503. PubMed ID: 21767857
[TBL] [Abstract][Full Text] [Related]
14. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo.
Xiang DB; Chen ZT; Wang D; Li MX; Xie JY; Zhang YS; Qing Y; Li ZP; Xie J
Cancer Gene Ther; 2008 Oct; 15(10):625-35. PubMed ID: 18535621
[TBL] [Abstract][Full Text] [Related]
15. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
16. Immortalization of human cells by mutant and chimeric primate polyomavirus T-antigen genes.
O'Neill FJ; Frisque RJ; Xu X; Hu YX; Carney H
Oncogene; 1995 Mar; 10(6):1131-9. PubMed ID: 7700639
[TBL] [Abstract][Full Text] [Related]
17. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
Kaszubiak A; Holm PS; Lage H
Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
[TBL] [Abstract][Full Text] [Related]
18. BK virus as a potential co-factor in human cancer.
Harris KF; Chang E; Christensen JB; Imperiale MJ
Dev Biol Stand; 1998; 94():81-91. PubMed ID: 9776229
[TBL] [Abstract][Full Text] [Related]
19. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells.
Waheed I; Guo ZS; Chen GA; Weiser TS; Nguyen DM; Schrump DS
Cancer Res; 1999 Dec; 59(24):6068-73. PubMed ID: 10626792
[TBL] [Abstract][Full Text] [Related]
20. Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway.
McCabe MT; Low JA; Imperiale MJ; Day ML
Oncogene; 2006 May; 25(19):2727-35. PubMed ID: 16547506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
